HUP0100115A2 - Eljárás kóros vágy csökkentésére emlősökben - Google Patents

Eljárás kóros vágy csökkentésére emlősökben

Info

Publication number
HUP0100115A2
HUP0100115A2 HU0100115A HUP0100115A HUP0100115A2 HU P0100115 A2 HUP0100115 A2 HU P0100115A2 HU 0100115 A HU0100115 A HU 0100115A HU P0100115 A HUP0100115 A HU P0100115A HU P0100115 A2 HUP0100115 A2 HU P0100115A2
Authority
HU
Hungary
Prior art keywords
mammals
reducing
mammal
reducing craving
craving
Prior art date
Application number
HU0100115A
Other languages
English (en)
Inventor
Vicki Coffin
Paul W. Glue
Original Assignee
Schering Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp. filed Critical Schering Corp.
Publication of HUP0100115A2 publication Critical patent/HUP0100115A2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány étel vagy egy additív anyag iránti kóros vágy emlősbenvaló csökkentésére alkalmas eljárásra vonatkozik. Az eljárás abbóláll, hogy egy Dl/D5 antagonista vagy egy D1/D5 parciális agonistahatásos mennyiségét adják be egy emlősnek, vagy egyedül vagy más,meghatározott CNS vegyületekkel kombinációban. Ó
HU0100115A 1997-10-28 1998-10-26 Eljárás kóros vágy csökkentésére emlősökben HUP0100115A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95921397A 1997-10-28 1997-10-28
PCT/US1998/022255 WO1999021540A2 (en) 1997-10-28 1998-10-26 Method of reducing craving in mammals

Publications (1)

Publication Number Publication Date
HUP0100115A2 true HUP0100115A2 (hu) 2001-06-28

Family

ID=25501785

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100115A HUP0100115A2 (hu) 1997-10-28 1998-10-26 Eljárás kóros vágy csökkentésére emlősökben

Country Status (16)

Country Link
EP (1) EP1043980A2 (hu)
JP (1) JP2001520989A (hu)
KR (1) KR20010031470A (hu)
CN (1) CN1283116A (hu)
AR (1) AR015984A1 (hu)
AU (1) AU1110099A (hu)
BR (1) BR9814830A (hu)
CA (1) CA2308453A1 (hu)
CO (1) CO4970824A1 (hu)
HU (1) HUP0100115A2 (hu)
IL (1) IL135659A0 (hu)
NO (1) NO20002149L (hu)
PE (1) PE122299A1 (hu)
SK (1) SK5812000A3 (hu)
WO (1) WO1999021540A2 (hu)
ZA (1) ZA989786B (hu)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6410527B1 (en) * 1998-03-02 2002-06-25 Schering Corporation Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
US6541520B1 (en) 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
US6890951B2 (en) 1998-08-05 2005-05-10 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
IL137937A0 (en) * 1999-08-27 2001-10-31 Pfizer Prod Inc A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US6395783B1 (en) 2000-10-23 2002-05-28 Brookhaven Science Associates, Llc Treatment of PCP addiction and PCP addiction-related behavior
US6462084B1 (en) 2001-05-14 2002-10-08 Brookhaven Science Associates, Llc Treatment for obsessive-compulsive disorder (OCD) and OCD-related disorders using GVG
NZ532583A (en) 2001-11-05 2006-12-22 Krele Pharmaceuticals Compositions and methods for increasing compliance using aldehyde dehydrogenase inhibitors ( ALDH ) such as disulfiram and monoamine oxidase B inhibitors ( MAOB ) such as selegiline
JP6355921B2 (ja) 2010-09-01 2018-07-11 トニックス ファーマスーティカルズ, インコーポレイテッドTONIX Pharmaceuticals, Inc. コカイン嗜癖の治療
EP2872145B8 (en) 2012-07-12 2022-04-13 Emalex Biosciences, Inc. Fused benzazepines for treatment of tourette's syndrome
RS60556B1 (sr) * 2013-10-18 2020-08-31 Emalex Biosciences Inc Kondenzovani benzazepini za lečenje mucanja
CN110327350B (zh) * 2019-07-11 2021-02-23 温州医科大学 多巴胺d1受体拮抗剂sch39166在作为制备治疗眼部病理性血管新生药物的应用
CN110833621A (zh) * 2019-12-06 2020-02-25 中国医科大学 多巴胺受体1拮抗剂在制备治疗对氯胺酮致小鼠类精神分裂症药物上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607967A (en) * 1994-10-27 1997-03-04 Merck & Co., Inc. Treatment of alzheimer's disease with 5-(tetradecyloxy)-2-furan carboxylic acid
WO1997046239A1 (en) * 1996-06-06 1997-12-11 Ergo Research Corporation Treatment of lipid and glucose metabolism disorders with dopamine and serotonin agonists

Also Published As

Publication number Publication date
JP2001520989A (ja) 2001-11-06
WO1999021540A3 (en) 1999-09-02
WO1999021540B1 (en) 1999-10-28
NO20002149D0 (no) 2000-04-27
ZA989786B (en) 1999-04-28
AU1110099A (en) 1999-05-17
NO20002149L (no) 2000-06-26
EP1043980A2 (en) 2000-10-18
IL135659A0 (en) 2001-05-20
WO1999021540A2 (en) 1999-05-06
BR9814830A (pt) 2000-10-03
AR015984A1 (es) 2001-05-30
CN1283116A (zh) 2001-02-07
PE122299A1 (es) 1999-12-04
SK5812000A3 (en) 2000-12-11
CO4970824A1 (es) 2000-11-07
CA2308453A1 (en) 1999-05-06
KR20010031470A (ko) 2001-04-16

Similar Documents

Publication Publication Date Title
ID21020A (id) Komposisi aditif deterjen untuk bahan bakar diesel
NO994055L (no) Brennstoff med smorende additiv
HUP0100115A2 (hu) Eljárás kóros vágy csökkentésére emlősökben
DE19983758T1 (de) Dieselkraftstoffzusammensetzung
NO993739D0 (no) Dieseladditiv for å forbedre cetan, smöreevne og stabilitet
ATE274805T1 (de) Zusatzstoff für transkutane immunisierung
NO985533D0 (no) Additiver til brennstoff
ATE322640T1 (de) Schraubverbindung für innenplattierte rohre
ATE351896T1 (de) Brennstoffzusammensetzung
GB9924756D0 (en) Lubricant composition for diesel engines
NO995255D0 (no) FremgangsmÕte for Õ produsere fiskeforpellets med höyt oljeinnhold
ID16380A (id) Kopolimer akrilik sebagai aditif untuk menghambat pengendapan parafin dalam minyak mentah dan komposisi yang mengandung minyak dan aditif tersebut
EP1122295A4 (en) PETROL ADDITIVE FOR A DIRECT INJECTION PETROL ENGINE
IS5382A (is) Setin 4-oxo-napthyridine-3-karboxamíð sem tengistGABA viðtökum í heila
PL346615A1 (en) Fuel additive composition and method for the treatment of fuels
HUP0102107A3 (en) Solid fuel additive
DE69702421T2 (de) Viertaktbrennkraftmaschine in V Bauart für Motorrad
NO20005360L (no) Sammensetning for fremstilling av brennstoffbriketter
AU3092200A (en) Method for determining the needed amount of structure modifying agent to be added to cast iron
DE69805225D1 (de) Schmierzusatzverwendung zur Schaumverminderung in Brennstoffen
DE69712886D1 (de) Schmierung für motoren
NO991713L (no) Additiver med sm°reevne for brennoljesammensetninger
DK1123364T3 (da) Additivsammensætning til dieselbtrændstof og fremgangsmåde til behandling af dieselbrændstoffer
IL140858A0 (en) Endogenous constitutively activated g protein-coupled orphan receptors
IT1305390B1 (it) Metodo per la determinazione dell'andamento della coppia dicarico in un motore endotermico